Her 2 and topoisomerase (TOPO)IIα as predictive markers for node-positive (N+) breast cancer (BC) patients (PTS) randomised to adjuvant CMF or epirubicin (E) — cyclophosphamide (C)

✍ Scribed by A. Di Leo; D. Larsimont; M. Beauduin; A. Vindevoghel; J. Michel; S. Dolci; S. Bartolomeus; J.P. Lobelle; M. Paesmans; M. Piccart

• Book ID: 117667770
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 265 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(99)81230-1